✦ LIBER ✦

169 Phase III trial of paclitaxel (P) and oral etoposide (E) in patients with small cell (SCLC) or non-small cell (NSCLC) lung cancer

✍ Scribed by Boyer, M.J.; Zalcberg, J.; Olver, L.N.; Millward, M.J.; Richardson, G.; McKeage, M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

35 A sequence-dependent paclitaxel-etopo

✍ Massuti, B.; Felip, E.; González-Larriba, J.L.; Benito, D.; López-Cabrerizo, M.P 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 161 KB

Phase II studies of topotecan in patient

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 132 KB

Phase II study of paclitaxel and oral et

✍ Boyer, Michael J; Mitchell, Paul; Goldstein, David; Millward, Michael J; Olver, 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 71 KB

528 Phase III trial of paclitaxel (Taxol

✍ Kirkbride, P.; Eisenhauer, E.; Gelmon, K.; Fisher, B.; Delude, H. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 163 KB

Phase III trial of paclitaxel (P), carbo

✍ Socinski, MA; Sandler, AB; Petit, RG; Steagall, A; Hanover, CK; Natale, RB; Mill 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 212 KB

P-562 Phase I clinical trial with Topote

✍ Padmanabhan, Swaminathan; Raez, Luis E.; Santos, Edgardo; Tang, Shou-ching; Ramo 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 188 KB